EARLY OUTCOMES OF ARTERIOVENOUS FISTULA INTERVENTION AT FRIENDSHIP HOSPITAL
Main Article Content
Abstract
Objectives: To describe clinical and lesional characteristics and evaluate early outcomes (after 1 month) of endovascular intervention for arteriovenous access stenosis in hemodialysis patients.
Subjects and methods: A descriptive, retrospective and prospective study on 47 end-stage renal disease patients on hemodialysis with significant access stenosis (> 50%) who underwent endovascular intervention at Friendship Hospital from 3/2023 to 12/2024.
Results: The mean age of the patients was 71.9 ± 10.9 years, with 87.2% males. Hypertension (76.6%) and diabetes (53.2%) were common comorbidities. Radiocephalic arteriovenous fistula accounted for 76.6%. The most common stenosis location was the juxta-anastomotic area (51.1%), with a mean stenosis degree of 81.7 ± 10.3%, and lesion length of 42 ± 14 mm. Mean access flow before intervention was 350.7 ± 220.3 ml/min. Technical and clinical success rates were 100%. Post-intervention access flow improved significantly (654.7 ± 320.6 ml/min, p < 0.001). Minor complications included access site bleeding (6.4%) and venous spasm (8.5%). The 1-month restenosis rate was 4.3%.
Conclusion: Endovascular intervention is a safe and highly effective method for treating arteriovenous access stenosis, especially in elderly patients, helping to restore and maintain hemodialysis functionality.
Article Details
Keywords
Arteriovenous fistula stenosis, endovascular intervention, balloon angioplasty, hemodialysis.
References
[2] Brahmbhatt A, Remuzzi A, Franzoni M, Misra S. The molecular mechanisms of hemodialysis vascular access failure. Kidney Int, 2016, 89 (2): 303-316. doi: 10.1016/j.kint.2015.12.019.
[3] KDOQI, National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis, 2006, 47 (5 Suppl 3): S11-S145. doi: 10.1053/j.ajkd.2006.03.010.
[4] Viecelli A.K et al. Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. Am J Kidney Dis, 2018, 71 (5): 690-700. doi: 10.1053/j.ajkd.2017.12.003.
[5] Schwab S.J, Oliver M.J, Suhocki P, McCann R. Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. Kidney Int.,2001, 59 (1): 358-362. doi: 10.1046/j.1523-1755.2001.00498.x.
[6] Lotfi U, Mostafa H. Evaluation of the endovascular salvage outcome for dysfunctional arteriovenous fistula for hemodialysis according to the site of the lesion. J Cardiol & Cardiovasc Ther, 2017, 2 (5): 1-8. doi: 10.19080/JOCCT.2017.02.555596
[7] Beathard G.A. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int, 1992, 42 (6): 1390-1397. doi: 10.1038/ki.1992.431.
[8] Aktas A, Bozkurt A, Aktas H et al. Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency. Diagn Interv Radiol, 2015, 21 (2): 160-166. doi: 10.5152/dir.2014.14348.